Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Immuneering (IMRX) Accumulated Depreciation & Amortization (2020 - 2024)

Immuneering has reported Accumulated Depreciation & Amortization over the past 5 years, most recently at $88949.0 for Q3 2024.

  • Quarterly results put Accumulated Depreciation & Amortization at $88949.0 for Q3 2024, up 13.61% from a year ago — trailing twelve months through Sep 2024 was $88949.0 (up 13.61% YoY), and the annual figure for FY2023 was $322816.0, down 22.83%.
  • Accumulated Depreciation & Amortization for Q3 2024 was $88949.0 at Immuneering, down from $90533.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for IMRX hit a ceiling of $418337.0 in Q4 2022 and a floor of $54560.0 in Q2 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $128752.0 (2020), compared with a mean of $153368.5.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 140.12% in 2022 and later crashed 65.52% in 2023.
  • Immuneering's Accumulated Depreciation & Amortization stood at $128752.0 in 2020, then skyrocketed by 35.31% to $174219.0 in 2021, then surged by 140.12% to $418337.0 in 2022, then fell by 22.83% to $322816.0 in 2023, then plummeted by 72.45% to $88949.0 in 2024.
  • The last three reported values for Accumulated Depreciation & Amortization were $88949.0 (Q3 2024), $90533.0 (Q2 2024), and $90209.0 (Q1 2024) per Business Quant data.